Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of Ultraviolet Radiation and Benzo[a]pyrene Co-Exposure on Skin Biology: Autophagy as a Potential Target.

Autor: Fayyad-Kazan, Mohammad¹ (AUTHOR), Kobaisi, Farah² (AUTHOR), Nasrallah, Ali² (AUTHOR), Matarrese, Patrick³ (AUTHOR), Fitoussi, Richard³ (AUTHOR), Bourgoin-Voillard, Sandrine⁴ (AUTHOR), Seve, Michel⁴ (AUTHOR) michel.seve@univ-grenoble-alpes.fr, Rachidi, Walid² (AUTHOR) michel.seve@univ-grenoble-alpes.fr

Publikováno v: International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 6, p5863. 11p.

Criblage à haut contenu à base d'ARNi et de produits chimiques pour la normalisation du phénotype XPC

Autor: Kobaisi, Farah

Publikováno v: Health. Université Grenoble Alpes [2020-..], 2021. English. ⟨NNT : 2021GRALS017⟩

Xeroderma Pigmentosium C (XP-C) is a rare autosomal recessive genodermatosis. Patients with this disorder carry a mutation in the DNA damage recognition protein XPC belonging to the nucleotide excision repair (NER) pathway. This mutation generates a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3515::0a9a9e0153a65ae67aeb03f941377004
https://theses.hal.science/tel-04098621

High-throughput synthetic rescue for exhaustive characterization of suppressor mutations in human genes

Autor: Kobaisi, Farah, Fayyad, Nour, Sulpice, Eric, Badran, Bassam, Fayyad-Kazan, Hussein, Rachidi, Walid, Gidrol, Xavier

Publikováno v: Cellular and Molecular Life Sciences
Cellular and Molecular Life Sciences, 2020, 77 (21), pp.4209-4222. ⟨10.1007/s00018-020-03519-6⟩

International audience; Abstract Inherited or acquired mutations can lead to pathological outcomes. However, in a process defined as synthetic rescue, phenotypic outcome created by primary mutation is alleviated by suppressor mutations. An exhaustive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3515::80726db41dc1df2154299cc4bc5b19a9
https://hal.science/hal-03656568

Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells.

Autor: Carré A; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Zhou Z; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Perez-Hernandez J; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.; Department of Nutrition and Health, Valencian International University (VIU), Valencia, Spain., Samassa F; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Lekka C; Islet Biology Group, Exeter Centre of Excellence in Diabetes Research, University of Exeter Medical School, Exeter, UK., Manganaro A; Diabetes Center of Excellence, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Oshima M; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Liao H; Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, UK., Parker R; Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, UK., Nicastri A; Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, UK., Brandao B; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Colli ML; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium., Eizirik DL; ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium., Göransson M; Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark., Morales OB; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Anderson A; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Landry L; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Kobaisi F; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Scharfmann R; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France., Marselli L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Marchetti P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., You S; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.; Indiana Biosciences Research Institute, Indianapolis, IN, USA., Nakayama M; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Hadrup SR; Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark., Kent SC; Diabetes Center of Excellence, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Richardson SJ; Islet Biology Group, Exeter Centre of Excellence in Diabetes Research, University of Exeter Medical School, Exeter, UK., Ternette N; Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, UK., Mallone R; Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France.; Indiana Biosciences Research Institute, Indianapolis, IN, USA.; Assistance Publique Hôpitaux de Paris, Service de Diabétologie et Immunologie Clinique, Cochin Hospital, Paris, France.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 17. Date of Electronic Publication: 2023 Sep 17.